About 1 result found for searched term "Indatuximab" (0.082 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M66371 | Indatuximab | Immunology/Inflammation |
| Anti-Syndecan-1/CD138 Antibody | ||
| Indatuximab is a chimeric antibody that targets Syndecan-1/CD138. The predicted molecular weight (MW) of Indatuximab is 145.5 kDa. Indatuximab can be used for the research of multiple myeloma and CD138-positive solid tumors. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
